Follow the Raptor Pharmaceutical Corp stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €7.2m. The latest transaction was filed on 11 February 2016 (Attribution). Among the most active insiders: Gould Ashley C.. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 25,371 of 28,892 companies
24.2
score / 100
Value
9
Quality
40
FCF yld-25%
Earn yld-26%
EV/EBITDA·
ROE-72%
Gross mgn87%
Net mgn-2.3%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Raptor Pharmaceutical Corp is a company focused on developing treatments for rare diseases. It aims to provide innovative solutions to enhance the quality of life for patients.